Zhiping Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zhiping Xie has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Bin Xi
Department of Neurosurgery, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College
4 shared publicationsDengfeng Wan
Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang
2 shared publicationsJieping Fu
The Second People’s Hospital of Yichun City, Yichun
2 shared publications- Meihua Li
Department of Neurosurgery, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17 Yongwaizheng Street, Nanchang, 330006, Jiangxi, China
2 shared publications - Shenke Xie
Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China
2 shared publications - Wu Zhou
Department of Neurosurgery, the 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
2 shared publications
Latest Publications
- 6 December 2024
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (2) , e203-e205
Arachnoid Cyst Associated With Traumatic Chronic Subdural Hemorrhage in Children
Introduction: It was reported that most arachnoid cyst (AC)-associated chronic subdural hematoma (CSDH) was spontaneous. However, AC with CSDH caused by trauma was extremely scarcely reported. In this paper, the authors reported a successful surgical treatment of a case of AC associated with CSDH after trauma. Case Presentation: A 15-year-old girl was admitted with headache and vomiting persisting for 3 days following a head injury received 1 month previously. Head magnetic resonance imaging (MRI) showed a left temporal AC and ipsilateral CSDH. Digital subtraction angiography (DSA) of the brain showed no vascular abnormalities. The patient underwent a left burr hole irrigation and drainage (BHID). The patient recovered well after surgery and was discharged 4 days later. Clinical Discussion: This event’s pathogenesis is thought to be caused by vascular rupture around AC. It can not only occur spontaneously but also be caused by varying degrees of head trauma. Surgery is the most common and effective treatment, including BHID, partial/subtotal membrane resection, endoscopic fenestration, and so on. Conclusion: Arachnoid cyst (AC) with traumatic CSDH is an extremely scarce condition. Surgery is the most common and effective treatment. Moreover, it is necessary to perform DSA before surgery to rule out cerebral vascular malformations in children and adolescents.
- 6 December 2024
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (2) , e203-e205
Arachnoid Cyst Associated With Traumatic Chronic Subdural Hemorrhage in Children
Introduction: It was reported that most arachnoid cyst (AC)-associated chronic subdural hematoma (CSDH) was spontaneous. However, AC with CSDH caused by trauma was extremely scarcely reported. In this paper, the authors reported a successful surgical treatment of a case of AC associated with CSDH after trauma. Case Presentation: A 15-year-old girl was admitted with headache and vomiting persisting for 3 days following a head injury received 1 month previously. Head magnetic resonance imaging (MRI) showed a left temporal AC and ipsilateral CSDH. Digital subtraction angiography (DSA) of the brain showed no vascular abnormalities. The patient underwent a left burr hole irrigation and drainage (BHID). The patient recovered well after surgery and was discharged 4 days later. Clinical Discussion: This event’s pathogenesis is thought to be caused by vascular rupture around AC. It can not only occur spontaneously but also be caused by varying degrees of head trauma. Surgery is the most common and effective treatment, including BHID, partial/subtotal membrane resection, endoscopic fenestration, and so on. Conclusion: Arachnoid cyst (AC) with traumatic CSDH is an extremely scarce condition. Surgery is the most common and effective treatment. Moreover, it is necessary to perform DSA before surgery to rule out cerebral vascular malformations in children and adolescents.
- 3 July 2024
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part A: Central European Neurosurgery
- Vol. 86 (01) , 017-029
Elevated HSPB1 Expression Is Associated with a Poor Prognosis in Glioblastoma Multiforme Patients
Background Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer. This study investigated the clinical predictive value of heat shock protein β1 (HSPB1) in patients with GBM. Methods A correlation was established between HSPB1 expression and GBM progression using data from The Cancer Genome Atlas (TCGA) dataset, Chinese Glioma Genome Atlas dataset, Gene Expression Omnibus dataset, and Human Protein Atlas database. A survival analysis was conducted and an HSPB1-based nomogram was constructed to evaluate the prognostic value of HSPB1 in patients with GBM. Results Based on TCGA data mining, we discovered that HSPB1 was significantly elevated in patients with GBM and may reflect their response to immunotherapy. In survival analysis, it appeared to have a predictive role in the prognosis of patients with GBM. Five signaling pathways were significantly enriched in the high HSPB1 expression phenotype according to the gene set enrichment analysis. In addition, a significant association was found between HSPB1 expression and immune checkpoints, tumor immune infiltration, tumor immune microenvironment, and immune cell markers in glioma. Overall, our results suggest that HSPB1 may regulate the function of immune cells, serve as a new immunotherapy target, and predict the response to immunotherapy in patients with GBM. Conclusion HSPB1 appears to serve as a potential predictor of the clinical prognosis and response to immunotherapy in patients with GBM. It may be possible to identify patients who are likely to benefit from immunotherapy by assessing the expression level of HSPB1.
- 3 July 2024
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part A: Central European Neurosurgery
- Vol. 86 (01) , 017-029
Elevated HSPB1 Expression Is Associated with a Poor Prognosis in Glioblastoma Multiforme Patients
Background Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer. This study investigated the clinical predictive value of heat shock protein β1 (HSPB1) in patients with GBM. Methods A correlation was established between HSPB1 expression and GBM progression using data from The Cancer Genome Atlas (TCGA) dataset, Chinese Glioma Genome Atlas dataset, Gene Expression Omnibus dataset, and Human Protein Atlas database. A survival analysis was conducted and an HSPB1-based nomogram was constructed to evaluate the prognostic value of HSPB1 in patients with GBM. Results Based on TCGA data mining, we discovered that HSPB1 was significantly elevated in patients with GBM and may reflect their response to immunotherapy. In survival analysis, it appeared to have a predictive role in the prognosis of patients with GBM. Five signaling pathways were significantly enriched in the high HSPB1 expression phenotype according to the gene set enrichment analysis. In addition, a significant association was found between HSPB1 expression and immune checkpoints, tumor immune infiltration, tumor immune microenvironment, and immune cell markers in glioma. Overall, our results suggest that HSPB1 may regulate the function of immune cells, serve as a new immunotherapy target, and predict the response to immunotherapy in patients with GBM. Conclusion HSPB1 appears to serve as a potential predictor of the clinical prognosis and response to immunotherapy in patients with GBM. It may be possible to identify patients who are likely to benefit from immunotherapy by assessing the expression level of HSPB1.
- 1 March 2023
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 34 (5) , 290-298
Ginsenoside Rg1 attenuation of neurogenesis disorder and neuronal apoptosis in the rat hippocampus after spinal cord injury may involve brain-derived neurotrophic factor/extracellular signal-regulated kinase signaling
Objective: We previously demonstrated that spinal cord injury (SCI) induced hippocampus injury and depression in rodents. Ginsenoside Rg1 effectively prevents neurodegenerative disorders. Here, we investigated the effects of ginsenoside Rg1 on the hippocampus after SCI. Methods: We used a rat compression SCI model. Western blotting and morphologic assays were used to investigate the protective effects of ginsenoside Rg1 in the hippocampus. Results: Brain-derived neurotrophic factor/extracellular signal-regulated kinases (BDNF/ERK) signaling was altered in the hippocampus at 5 weeks after SCI. SCI attenuated neurogenesis and enhanced the expression of cleaved caspase-3 in the hippocampus; however, ginsenoside Rg1 attenuated cleaved caspase-3 expression and improved neurogenesis and BDNF/ERK signaling in the rat hippocampus. The results suggest that SCI affects BDNF/ERK signaling, and ginsenoside Rg1 can attenuate hippocampal damage after SCI. Conclusion: We speculate that the protective effects of ginsenoside Rg1 in hippocampal pathophysiology after SCI may involve BDNF/ERK signaling. Ginsenoside Rg1 shows promise as a therapeutic pharmaceutical product when seeking to counter SCI-induced hippocampal damage.
- 1 March 2023
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 34 (5) , 290-298
Ginsenoside Rg1 attenuation of neurogenesis disorder and neuronal apoptosis in the rat hippocampus after spinal cord injury may involve brain-derived neurotrophic factor/extracellular signal-regulated kinase signaling
Objective: We previously demonstrated that spinal cord injury (SCI) induced hippocampus injury and depression in rodents. Ginsenoside Rg1 effectively prevents neurodegenerative disorders. Here, we investigated the effects of ginsenoside Rg1 on the hippocampus after SCI. Methods: We used a rat compression SCI model. Western blotting and morphologic assays were used to investigate the protective effects of ginsenoside Rg1 in the hippocampus. Results: Brain-derived neurotrophic factor/extracellular signal-regulated kinases (BDNF/ERK) signaling was altered in the hippocampus at 5 weeks after SCI. SCI attenuated neurogenesis and enhanced the expression of cleaved caspase-3 in the hippocampus; however, ginsenoside Rg1 attenuated cleaved caspase-3 expression and improved neurogenesis and BDNF/ERK signaling in the rat hippocampus. The results suggest that SCI affects BDNF/ERK signaling, and ginsenoside Rg1 can attenuate hippocampal damage after SCI. Conclusion: We speculate that the protective effects of ginsenoside Rg1 in hippocampal pathophysiology after SCI may involve BDNF/ERK signaling. Ginsenoside Rg1 shows promise as a therapeutic pharmaceutical product when seeking to counter SCI-induced hippocampal damage.
- Open Access
- 3 January 2023
- Published by Springer Nature in Research Square
Ginsenoside Rg1 attenuates neurogenesis disorder and neuronal apoptosis in the rat hippocampus after spinal cord injury may involve BDNF/ERK signaling
Objective: Our previous results have demonstrated that spinal cord injury(SCI) can induce hippocampus injury and depression in rodents. Ginsenoside Rg1 is efficient to prevent neurodegenerative disorders. This study aim to investigate the effects of ginsenoside Rg1 in hippocampus after SCI. Method:We used a rat compression SCI model. Western blotting and morphological assays were used to investigate protective effects of Ginsenoside Rg1 in the hippocampus. Results: The results demonstrated that BDNF/ERK signaling is altered in the hippocampus at 5 weeks after SCI. SCI attenuates neurogenesis and enhances the expression of cleaved caspase-3 in the hippocampus. Moreover, ginsenoside Rg1 can attenuate the expression of cleaved caspase-3 and improve the number of neurogenesis and the expression of BDNF/ERK signaling in the rat hippocampus. The results thus suggest that SCI affects BDNF/ERK signaling, and ginsenoside Rg1 can attenuate the damage of hippocampus after SCI. Conclusion:We speculate that the protective effects of ginsenoside Rg1 in hippocampal pathophysiological after SCI may involve BDNF/ERK signaling. Ginsenoside Rg1 may serve as a therapeutic pharmaceutical product in the futurewhen seeking to counter SCI-induced hippocampal damage.
- 3 January 2023
- Published by Springer Nature in Research Square
Open AccessGinsenoside Rg1 attenuates neurogenesis disorder and neuronal apoptosis in the rat hippocampus after spinal cord injury may involve BDNF/ERK signaling
Objective: Our previous results have demonstrated that spinal cord injury(SCI) can induce hippocampus injury and depression in rodents. Ginsenoside Rg1 is efficient to prevent neurodegenerative disorders. This study aim to investigate the effects of ginsenoside Rg1 in hippocampus after SCI. Method:We used a rat compression SCI model. Western blotting and morphological assays were used to investigate protective effects of Ginsenoside Rg1 in the hippocampus. Results: The results demonstrated that BDNF/ERK signaling is altered in the hippocampus at 5 weeks after SCI. SCI attenuates neurogenesis and enhances the expression of cleaved caspase-3 in the hippocampus. Moreover, ginsenoside Rg1 can attenuate the expression of cleaved caspase-3 and improve the number of neurogenesis and the expression of BDNF/ERK signaling in the rat hippocampus. The results thus suggest that SCI affects BDNF/ERK signaling, and ginsenoside Rg1 can attenuate the damage of hippocampus after SCI. Conclusion:We speculate that the protective effects of ginsenoside Rg1 in hippocampal pathophysiological after SCI may involve BDNF/ERK signaling. Ginsenoside Rg1 may serve as a therapeutic pharmaceutical product in the futurewhen seeking to counter SCI-induced hippocampal damage.
- 1 June 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 756, 135965
Driving effect of BDNF in the spinal dorsal horn on neuropathic pain
- 1 June 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 756, 135965
Driving effect of BDNF in the spinal dorsal horn on neuropathic pain
- 7 April 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 1-11
The Notch Signaling Pathway Regulates Differentiation of NG2 Cells into Oligodendrocytes in Demyelinating Diseases
NG2 cells are highly proliferative glial cells that can self-renew or differentiate into oligodendrocytes, promoting remyelination. Following demyelination, the proliferative and differentiation potentials of NG2 cells increase rapidly, enhancing their differentiation into functional myelinating cells. Levels of the transcription factors Olig1 and Olig2 increase during the differentiation of NG2 cells and play important roles in the development and repair of oligodendrocytes. However, the ability to generate new oligodendrocytes is hampered by injury-related factors (e.g., myelin fragments, Wnt and Notch signaling components), leading to failed differentiation and maturation of NG2 cells into oligodendrocytes. Here, we review Notch signaling as a negative regulator of oligodendrocyte differentiation and discuss the extracellular ligands, intracellular pathways, and key transcription factors involved.
- 7 April 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 1-11
The Notch Signaling Pathway Regulates Differentiation of NG2 Cells into Oligodendrocytes in Demyelinating Diseases
NG2 cells are highly proliferative glial cells that can self-renew or differentiate into oligodendrocytes, promoting remyelination. Following demyelination, the proliferative and differentiation potentials of NG2 cells increase rapidly, enhancing their differentiation into functional myelinating cells. Levels of the transcription factors Olig1 and Olig2 increase during the differentiation of NG2 cells and play important roles in the development and repair of oligodendrocytes. However, the ability to generate new oligodendrocytes is hampered by injury-related factors (e.g., myelin fragments, Wnt and Notch signaling components), leading to failed differentiation and maturation of NG2 cells into oligodendrocytes. Here, we review Notch signaling as a negative regulator of oligodendrocyte differentiation and discuss the extracellular ligands, intracellular pathways, and key transcription factors involved.